Cognizants Shared Investigator Platform SIP een life sciences SaaS-oplossing heeft een nieuwe mijlpaal bereikt van ruim 100000 gebruikers in 84 landen. The COVID-19 pandemic has changed the clinical trial landscape.
Shared Investigator Platform Joinsip Twitter
TEANECK NJ July 21 2020 PRNewswire -- Cognizant Nasdaq.
Cognizant shared investigator platform. Larissa Comis MJ joined Cognizant as the Shared Investigator Platform Lead about 6 months ago. CTSH announced that its Shared Investigator Platform SIP a life sciences Software as a Service SaaS solution has reached a new. CTSH announced that its Shared Investigator Platform SIP a life sciences Software as a Service SaaS solution has reached a new milestone of over 100000.
The Shared Investigator Platform is a critical initiative for TransCelerate and our membership. Announced the launch of the Shared Investigator Platform SIP a technology that will allow clinical trial sites to streamline investigative site information and establish a central access point for interaction between the site and multiple clinical trial. Since we launched it in 2016 some of our members are already experiencing the benefits of a single platform and we continue to collaborate closely with Cognizant and other partners to deliver enhanced usability and functionality throughout 2017 said Dalvir Gill.
Detta kan leda till förbättrad drifteffektivitet minskade kostnader för att skapa och underhålla egen teknik snabbare start av studien och mer tid. Cognizant Shared Investigator Platform SIP provides a way forward enabling sponsors to meet the challenges of the current environment. Shared Investigator Platform SIP is a multi-sponsor collaborative solution for clinical trial site selection start-up communications and management.
The Shared investigator platform is the first single instance multi-tenant technology platform in the clinical trials industryLearn more. Cognizant Shared Investigator Platform Machen Sie Schluss mit ineffektivem Verwaltungsaufwand bei klinischen Studien Das offene Design der Shared Investigator Platform SIP von Cognizant vereinfacht und beschleunigt klinische Studien weil redundante Arbeiten für Sponsoren und klinische Standorte vermieden werden. Het platform wordt steeds belangrijker voor de voortgang van klinische proeven omdat de huidige anderhalvemetersamenleving persoonlijke samenwerking aanzienlijk heeft ingeperkt.
The Cognizant Shared Investigator Platform SIP supports a new site-first approach for streamlining clinical trial processes. Esto puede llevar a mejoras en la eficiencia operativa costes reducidos de creación y mantenimiento de la tecnología interna un inicio más rápido de los estudios y mayor dedicación a los pacientes. Cognizant collaborates with Florence Healthcare to Integrate the Cognizant Shared Investigator Platform.
CTSH announced that its Shared Investigator Platform SIP a life sciences Software as a Service SaaS solution has reached a new milestone of over 100000 users in 84. Cognizant SIP is the only open collaborative clinical trial technology platform leveraging one environment across multiple sponsors and operating via common workflows and documents. When asked what made her decide to take the role she descri.
Florence eBinders eISF helps sites save time by reducing paperwork and giving clinical trial sponsors instant remote access to a vast majority of their study sites. The open design of Cognizants Shared Investigator Platform simplifies and accelerates clinical trials by eliminating redundant work for sponsors and clinical sites. Den öppna designen av Cognizants Shared Investigator Platform SIP Förenklar och effektiviserar kliniska prövningar genom att eliminera redundant arbete för sponsorer och kliniska platser elimineras.
El diseño abierto de Shared Investigator Platform SIP de Cognizant simplifica y acelera los ensayos clínicos al eliminar el trabajo repetitivo de patrocinadores y centros clínicos. The industrys first single-i. More than 100000 Life Sciences Researchers Clinicians and Professionals in 84 Countries Utilizing Innovative SaaS Solution to Help Speed New Drug Therapies to Market Cognizant Nasdaq.
CTSH announced that its Shared Investigator Platform SIP a life sciences Software as a Service SaaS solution has reached a new milestone of over 100000 users in 84 countries. TEANECK NJ July 21 2020 PRNewswire -- Cognizant Nasdaq. Cognizant Shared Investigator Platform Reduce costs improve investigator experience and accelerate clinical trials.
